Daily Magyar Nemzet reported in its Monday issue that the government told drug companies that drug subsidy measures to be introduced from July 1 would result in a HUF 25.9 billion net budget improvement.
Magyosz said drug makers were prepared to pay 5% of turnover from factory gate sales of subsidized drugs on the crisis tax.
Hungarian drug makers already pay a tax on sales of subsidized drugs as well as one on drug sales representatives.
Drug makers and the government finished the first round of talks on changes to the drug subsidy system last week, Magyosz said. More negotiations are to follow.
Preserving the country’s competitiveness and maintaining the operability of the healthcare sector are priorities from the point of view of Magyosz, the association said. A restructuring of the drug subsidy system should support the goal of increasing spending on research and development from 1.15% of GDP at present to 1.8% by 2020, it added.
The government’s recently unveiled Structural Reform Program, dubbed the Szell Kalman Plan, aims to improve the fiscal balance by HUF 83 billion in 2012 and HUF 120n in both 2013 and 2014 through changes to the drug subsidy system.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
